Achieve Life Sciences Inc (NASDAQ:ACHV)
| 6.44 Delayed Data As of Jun 01 |  +0.26 / +4.19%Today’s Change | 2.00 Today|||52-Week Range 10.30 | +162.86% Year-to-Date |
Latest ACHV News | Press Releases
No recent news for Achieve Life Sciences Inc.
Today’s Trading
| Previous close | 6.20 |
| Today’s open | 6.24 |
| Day’s range | 6.19 - 6.57 |
| Volume | 105,546 |
| Average volume (3 months) | 153,306 |
| Market cap | $131.0M |
Data as of 3:59pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | +2.08% |
| Earnings growth (this year) | +58.58% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 13.49 |
Competitors
| ---- | ||
| EPIXESSA Pharma Inc | -0.01 | -0.33% |
| GTHXG1 Therapeutics Inc | -0.01 | -0.39% |
| TRVITrevi Therapeutics I... | 0.00 | 0.00% |
Data as of 3:59pm ET, 06/01/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Vancouver, British Columbia |
Forecasts
